hydroxyindoleacetic acid has been researched along with Dyskinesia Syndromes in 45 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ventricular fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), the respective metabolites of dopamine and serotonin, were measured in 57 patients undergoing thalamotomy for relief of movement disorders." | 7.66 | Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. ( Sharpless, NS; Tabaddor, K; Wolfson, LI, 1978) |
| "Two cases of severe dystonia and dyskinesia were treated with talipexole, a dopamine autoreceptor agonist, and the metabolites of dopamine, norepinephrine, and serotonin in cerebrospinal fluid (CSF) were determined." | 3.68 | Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans. ( Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y; Yamada, S, 1990) |
| "Ventricular fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), the respective metabolites of dopamine and serotonin, were measured in 57 patients undergoing thalamotomy for relief of movement disorders." | 3.66 | Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. ( Sharpless, NS; Tabaddor, K; Wolfson, LI, 1978) |
| "We have studied the urinary excretion of 1,4-methylhistamine (1,4-MeHm), 5-hydroxyindole-3-acetic acid (5-HIAA) and homovanillic acid (HVA) in patients with Parkinson's disease, choreiform movements and essential tremor." | 3.65 | Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa. ( Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ, 1977) |
| "Haloperidol is a classical neuroleptic drug that is still in use and can lead to abnormal motor activity such as tardive dyskinesia (TD) following repeated administration." | 1.35 | Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2008) |
| "Results of long-term administration of L-threo-3,4-dihydroxyphenylserine (L-DOPS), a synthetic precursor of noradrenaline, in a patient with freezing gait and pure akinesia are reported." | 1.30 | Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy. ( Fujii, S; Hatanaka, Y; Yamamoto, M, 1997) |
| "In contrast to senile dementia of Alzheimer's type SLI was not correlated with dementia scores but with motor disease progression." | 1.28 | Parkinson's disease and dementia: clinical and neurochemical correlations. ( Cramer, H; Strittmatter, MM, 1992) |
| "Harmalan induced clonic convulsions which were antagonized by diazepam." | 1.27 | Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline). ( Brüning, G; Hill, R; Nick, M; Rommelspacher, H; Susilo, R, 1985) |
| "Treatment with tetrabenazine did not significantly alter the metabolite levels in patients in whom it produced either improvement, or side effects." | 1.26 | CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. ( Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (73.33) | 18.7374 |
| 1990's | 8 (17.78) | 18.2507 |
| 2000's | 2 (4.44) | 29.6817 |
| 2010's | 2 (4.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papandreou, A | 1 |
| Rahman, S | 1 |
| Fratter, C | 1 |
| Ng, J | 1 |
| Meyer, E | 1 |
| Carr, LJ | 1 |
| Champion, M | 1 |
| Clarke, A | 1 |
| Gissen, P | 1 |
| Hemingway, C | 1 |
| Hussain, N | 1 |
| Jayawant, S | 1 |
| King, MD | 1 |
| Lynch, BJ | 1 |
| Mewasingh, L | 1 |
| Patel, J | 1 |
| Prabhakar, P | 1 |
| Neergheen, V | 1 |
| Pope, S | 1 |
| Heales, SJR | 1 |
| Poulton, J | 1 |
| Kurian, MA | 1 |
| Creed, MC | 1 |
| Hamani, C | 1 |
| Bridgman, A | 1 |
| Fletcher, PJ | 1 |
| Nobrega, JN | 1 |
| BOZZI, R | 1 |
| BRUNO, A | 1 |
| ALLEGRANZA, A | 1 |
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Jeste, DV | 1 |
| Doongaji, DR | 1 |
| Linnoila, M | 1 |
| Kontur, PJ | 1 |
| al-Tikriti, M | 1 |
| Innis, RB | 1 |
| Roth, RH | 1 |
| Gil-Nagel, A | 1 |
| Morlán, L | 1 |
| Balseiro, J | 1 |
| García de Yébenes, J | 1 |
| Cabello, A | 1 |
| Martínez-Martín, P | 1 |
| Yamamoto, M | 2 |
| Fujii, S | 1 |
| Hatanaka, Y | 1 |
| Fall, PA | 1 |
| Ekman, R | 1 |
| Granérus, AK | 1 |
| Thorell, LH | 1 |
| Wålinder, J | 1 |
| Hyland, K | 1 |
| Beaman, BL | 1 |
| LeWitt, PA | 1 |
| DeMaggio, AJ | 1 |
| Klawans, H | 1 |
| Tabaddor, K | 1 |
| Wolfson, LI | 1 |
| Sharpless, NS | 1 |
| Wood, JH | 1 |
| Davidson, DL | 1 |
| Yates, CM | 1 |
| Mawdsley, C | 1 |
| Pullar, IA | 1 |
| Wilson, H | 1 |
| Rinne, UK | 1 |
| Siirtola, T | 1 |
| Sonninen, V | 1 |
| Diukova, GM | 1 |
| Bol'shakova, TD | 1 |
| Rodshtat, IV | 1 |
| Dibobes, GK | 1 |
| Tiabenkova, VF | 1 |
| Lenman, JA | 1 |
| Turnbull, MJ | 1 |
| Reid, A | 1 |
| Fleming, AM | 1 |
| Gerlach, J | 1 |
| Thorsen, K | 1 |
| Fog, R | 1 |
| García Ruiz, PJ | 1 |
| Mena, MA | 1 |
| Peñafiel, N | 1 |
| De Yébenes, JG | 1 |
| Strittmatter, MM | 1 |
| Cramer, H | 1 |
| Nishikawa, T | 1 |
| Yamada, S | 1 |
| Tsuda, A | 1 |
| Tanaka, M | 1 |
| Koga, I | 1 |
| Uchida, Y | 1 |
| Tanii, H | 1 |
| Hayashi, M | 1 |
| Hashimoto, K | 1 |
| Pagliusi, SR | 1 |
| Löscher, W | 1 |
| Ujike, H | 1 |
| Ogawa, N | 1 |
| Bradbury, AJ | 2 |
| Costall, B | 2 |
| Domeney, AM | 2 |
| Testa, B | 1 |
| Jenner, PG | 1 |
| Marsden, CD | 3 |
| Naylor, RJ | 2 |
| Kitatani, T | 1 |
| Hayashi, S | 1 |
| Sakaguchi, T | 1 |
| Jenner, PJ | 1 |
| Jankovic, J | 1 |
| Caskey, TC | 1 |
| Stout, JT | 1 |
| Butler, IJ | 1 |
| Kostic, V | 1 |
| Djuricic, B | 1 |
| Paschen, W | 1 |
| Rommelspacher, H | 1 |
| Brüning, G | 1 |
| Susilo, R | 1 |
| Nick, M | 1 |
| Hill, R | 1 |
| Birkmayer, W | 1 |
| Neumayer, E | 1 |
| Messiha, FS | 1 |
| Schnur, JA | 2 |
| Chase, TN | 2 |
| Brody, JA | 1 |
| Papeschi, R | 1 |
| Molina-Negro, P | 1 |
| Sourkes, TL | 1 |
| Erba, G | 1 |
| Curzon, G | 2 |
| Bazelon, M | 1 |
| Barnet, A | 1 |
| Lodge, A | 1 |
| Shelburne, SA | 1 |
| Pind, K | 1 |
| Faurbye, A | 1 |
| Cohen, DJ | 1 |
| Shaywitz, BA | 1 |
| Johnson, WT | 1 |
| Bowers, M | 1 |
| Sweet, RD | 1 |
| McDowell, FH | 1 |
| Guilleminault, C | 1 |
| Tharp, BR | 1 |
| Cousin, D | 1 |
| Parkes, JD | 1 |
| Rees, JE | 1 |
| Kantamaneni, BD | 1 |
| Knill-Jones, R | 1 |
| Akbar, A | 1 |
| Das, S | 1 |
| Kataria, M | 1 |
| Frankel, D | 1 |
| Khanna, JM | 1 |
| Kalant, H | 1 |
| LeBlanc, AE | 1 |
| Gordon, EK | 1 |
| O'Reilly, S | 2 |
| Loncin, M | 1 |
| Cooksey, B | 2 |
2 reviews available for hydroxyindoleacetic acid and Dyskinesia Syndromes
| Article | Year |
|---|---|
Amine precursors in neurologic disorders and the psychoses.
Topics: Acetylcholine; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindo | 1975 |
[Modern treatment of parkinsonism].
Topics: Antiparkinson Agents; Brain Stem; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Gastroin | 1972 |
1 trial available for hydroxyindoleacetic acid and Dyskinesia Syndromes
| Article | Year |
|---|---|
Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients.
Topics: Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Clozapine; Dibenzazepines; Haloperido | 1975 |
42 other studies available for hydroxyindoleacetic acid and Dyskinesia Syndromes
| Article | Year |
|---|---|
Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease.
Topics: Adolescent; Child; Child, Preschool; DNA Polymerase gamma; Female; Homovanillic Acid; Humans; Hydrox | 2018 |
Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analysis of Variance; Animals; Antipsychotic Agents; Autoradi | 2012 |
URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
Topics: Autonomic Nervous System Diseases; Chlorpromazine; Drug Therapy; Extrapyramidal Tracts; Fluids and S | 1965 |
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Calcium Channel Blockers; Calcium Cha | 2008 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovan | 1984 |
Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Dopamine; Huma | 1994 |
[Neuro-acanthocytosis with associated myopathy. A case report].
Topics: Acanthocytes; Adult; Basal Ganglia; Basophils; Brain Diseases; Cerebellum; Denervation; Homovanillic | 1994 |
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; | 1997 |
ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides.
Topics: Aged; Aged, 80 and over; Biogenic Monoamines; Electroconvulsive Therapy; Female; Homovanillic Acid; | 1995 |
Monoamine changes in the brain of BALB/c mice following sub-lethal infection with Nocardia asteroides (GUH-2).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Cerebellum; Dopamine; Female; H | 2000 |
Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
Topics: Adult; Aged; Cerebral Palsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Middle A | 1978 |
CSF HVA and 5-HIAA.
Topics: Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Movement Disorders; Phenylacetates | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; | 1977 |
L-deprenyl treatment of on-off phenomena in Parkinson's disease.
Topics: Aged; Benserazide; Dopamine; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydroxyin | 1978 |
[Clinico-neurohumoral interrelationships in neuroses].
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Catecholamines; Chromaffin System; Female; Humans; | 1978 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; | 1977 |
Cinnarizine-induced parkinsonism in primates.
Topics: Animals; Biogenic Monoamines; Cinnarizine; Disease Models, Animal; Dopamine; Haplorhini; Homovanilli | 1992 |
Parkinson's disease and dementia: clinical and neurochemical correlations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic A | 1992 |
Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Azepines; Dopamine Agents; Dystonia; Homovanillic Acid; Humans | 1990 |
Behavioral syndrome induced by allylnitrile, crotononitrile or 2-pentenenitrile in rats.
Topics: Animals; Behavior, Animal; Brain; Cyproheptadine; Fenclonine; Hydroxyindoleacetic Acid; Male; Methys | 1991 |
Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Body Weight; Brain Chemistry; Carbidopa; Drug Intera | 1985 |
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydro | 1985 |
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic | 1985 |
[Effects of pentoxifylline on 5-hydroxytryptamine in the mouse brain].
Topics: 5-Hydroxytryptophan; Animals; Brain; Drug Interactions; Hydroxyindoleacetic Acid; Male; Mice; Mice, | 1985 |
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic | 1986 |
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
Topics: Carbidopa; Catecholamines; Child; Child, Preschool; Fluphenazine; Glycols; Homovanillic Acid; Humans | 1988 |
Hemiballismus: changes in cerebrospinal fluid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Dominance, Cerebral; Dopamine; Female; Homovanillic Acid; Huma | 1988 |
Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline).
Topics: Animals; Behavior, Animal; Binding Sites; Carbolines; Cerebral Cortex; Convulsants; Female; Hydroxyi | 1985 |
A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
Topics: 5-Methoxytryptamine; Animals; Biogenic Amines; Chlorpromazine; Dopamine; Epinephrine; Female; Haplor | 1974 |
Parkinsonism-dementia of Guam: treatment with L-dopa.
Topics: Adult; Dementia; Dihydroxyphenylalanine; Drug Eruptions; Female; Humans; Hydroxyindoleacetic Acid; H | 1971 |
The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Cerebral Palsy; Cerebral Ventricles; Diazepam; Dihydroxyp | 1972 |
Involuntary movements other than Parkinsonism: biochemical aspects.
Topics: Acute Disease; Animals; Athetosis; Basal Ganglia; Brain; Dopamine; Fecal Incontinence; Homovanillic | 1973 |
The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
Topics: 5-Hydroxytryptophan; Age Factors; Central Nervous System; Chromosomes, Human, 21-22 and Y; Down Synd | 1968 |
Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
Topics: Dopamine; Humans; Hydroxyindoleacetic Acid; Movement Disorders; Phenylacetates; Probenecid; Schizoph | 1970 |
Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
Topics: Autistic Disorder; Brain; Child; Child, Preschool; Diagnosis, Differential; Dopamine; Electroencepha | 1974 |
Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.
Topics: Dietary Proteins; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levod | 1974 |
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Chorea; Dopamine; Dystonia Musculorum Deformans; Femal | 1973 |
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
Topics: Aged; Dementia; Dihydroxyphenylalanine; Electroencephalography; Female; Gait; Homovanillic Acid; Hum | 1974 |
Effect of acute and chronic ethanol administration on serotonin turnover in rat brain.
Topics: Administration, Oral; Animals; Brain; Brain Chemistry; Drug Tolerance; Ethanol; Hydroxyindoleacetic | 1974 |
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
Topics: Amines; Brain; Chlorpromazine; Extrapyramidal Tracts; Female; Humans; Hydroxyindoleacetic Acid; Move | 1970 |
Dopamine and basal ganglia disorders.
Topics: Adult; Basal Ganglia; Dopamine; Female; Hepatolenticular Degeneration; Humans; Hydroxyindoleacetic A | 1965 |
The relationship between 5-hydroxyindoles and catecholamines.
Topics: Blood-Brain Barrier; Brain Chemistry; Brain Diseases; Catecholamines; Dopamine; Female; Humans; Hydr | 1965 |